Synvect was founded by Nikolay Kandul, Omar Akbari, Pooja Y. Patel, Ravi Solanki in 2022.

Who are Synvect's investors?

Synvect's investors include Antler, NuFund Venture Group, Service Provider Capital, Bill & Melinda Gates Foundation, Redbud, Redbud VC.

How much funding has Synvect raised?

Synvect has disclosed $3M raised across 1 of its 2 known rounds.

Where is Synvect headquartered?

Synvect is headquartered in San Diego, US.

Synvect

San Diego, US · Founded 2022 · 6 employees on LinkedIn · 6 known investors

Find your way into Synvect

Paths you didn't know you had: your email and LinkedIn already hold routes to the Synvect team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering. The company serves public health organizations and disease control programs targeting mosquito-borne diseases worldwide.

AgTech Biotech Climate Tech Deep Tech Healthtech Impact & Social Good

Founders & leadership

Synvect was founded in 2022 by Nikolay Kandul, Omar Akbari, Pooja Y. Patel, and Ravi Solanki.

Nikolay Kandul Co-founder & CEONikolay Kandul is co-founder and CEO of Synvect, a biotechnology company developing genetic engineering solutions for mosquito control. He has background and expertise in entomology, evolutionary biology, genetics, and molecular biology.

Omar AkbariCo-founder & CSO

Pooja Y. Patel Co-founder & CBOPooja Y. Patel is co-founder and chief business officer of Synvect, which develops genetic engineering technology to control disease-carrying mosquitoes. She has a background in epidemiology.

Ravi SolankiCo-founder

Investors · 6

Antlerlisted by AntlerSingapore · $125K

How we know: funding news · Not right? Tell us

NuFund Venture Grouplisted by NuFund Venture GroupSan Diego · $1M

How we know: NuFund Venture Group's portfolio page · funding news · Not right? Tell us

Service Provider Capitallisted by Service Provider CapitalVail

Bill & Melinda Gates FoundationreportedSeattle

How we know: funding news · Not right? Tell us

RedbudreportedAustin

How we know: funding news · Not right? Tell us

Redbud VCreportedColumbia · $50K – $150K

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$3M disclosed across 1 of 2 rounds · 2025

$3MSeed FundingMar 2025 · 3 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Synvect Secures $3M Seed Round to Combat Mosquito-Borne Diseases with CRISPR Technology - BioSpacebiospace.com · Mar 2025

Synvect Raises $3M in Seed Fundingfinsmes.com · Mar 2025

Frequently asked questions

What does Synvect do?: Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering. The company serves public health organizations and disease control programs targeting mosquito-borne diseases worldwide.
Who founded Synvect?: Synvect was founded by Nikolay Kandul, Omar Akbari, Pooja Y. Patel, Ravi Solanki in 2022.
Who are Synvect's investors?: Synvect's investors include Antler, NuFund Venture Group, Service Provider Capital, Bill & Melinda Gates Foundation, Redbud, Redbud VC.
How much funding has Synvect raised?: Synvect has disclosed $3M raised across 1 of its 2 known rounds.
Where is Synvect headquartered?: Synvect is headquartered in San Diego, US.